Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardiff Oncology (CRDF) Interest & Investment Income (2023 - 2025)

Cardiff Oncology (CRDF) has disclosed Interest & Investment Income for 8 consecutive years, with $612000.0 as the latest value for Q4 2025.

  • Quarterly Interest & Investment Income fell 22.24% to $612000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Dec 2025, down 4.76% year-over-year, with the annual reading at $3.1 million for FY2025, 4.76% down from the prior year.
  • Interest & Investment Income hit $612000.0 in Q4 2025 for Cardiff Oncology, down from $716000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.1 million in Q3 2023 to a low of $612000.0 in Q4 2025.
  • Historically, Interest & Investment Income has averaged $862909.1 across 3 years, with a median of $835000.0 in 2025.
  • Biggest five-year swings in Interest & Investment Income: crashed 30.62% in 2024 and later grew 3.73% in 2025.
  • Year by year, Interest & Investment Income stood at $1.0 million in 2023, then fell by 21.92% to $787000.0 in 2024, then fell by 22.24% to $612000.0 in 2025.
  • Business Quant data shows Interest & Investment Income for CRDF at $612000.0 in Q4 2025, $716000.0 in Q3 2025, and $835000.0 in Q2 2025.